The global supplemental health market is on an upward trajectory, poised to generate substantial revenue growth, potentially climbing into the hundreds of millions over the forecast years from 2025 to 2034. This surge is attributed to evolving consumer preferences and technological advancements reshaping the industry.
The government organizations stay committed to advancing global healthcare. For instance, in March 2025, the World Health Organization (WHO) introduced the new health investment platform named the ‘health impact investment platform’ (HIIP) to advance primary healthcare and innovative financing for global health.
The World Bank is dedicated to providing financial and technical assistance to developing countries. For instance, in December 2024, the World Bank announced that the governing board of the Pandemic Fund approved a grant of $500 million for its third round of funding for the establishment of health systems in diagnostics, disease surveillance, laboratory systems, and health workforce to prevent and respond to pandemics, especially in low-and middle-income countries.
The R&D process for supplemental health includes idea generation, market analysis, product conceptualization and design, prototyping, regulatory compliance, testing, launch, post-launch monitoring, and optimization.
Key Players: Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Danaher Corporation, Stryker Corporation, Thermo Fisher Scientific Inc.
These services include wholesale distributors, group purchasing organizations, pharmacy services administrative organizations (PSAOs), and direct-to-consumer (D2C) models.
Key Players: McKesson Corporation, Cencora, Cardinal Health, Owens & Minor, Medline Industries, PHOENIX Group.
The various types of these services include supplemental insurance plans, employer-led programs, patient advocacy programs, pharma patient support programs, etc.
Key Players: UnitedHealth Group Incorporated, McKesson Corporation, McKesson Corporation, The Cigna Group, Cardinal Health, Inc.
In February 2025, Paul Virtell, vice president and chief product owner at Prudential Financial and Cigna Healthcare, said that the company and its team collaboration drives a culture of care while staying dedicated to improving the lives of customers. He also felt delighted to become a part of this team to embrace new opportunities and deliver a seamless customer experience.
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com
